Chest wall desmoid-type fibromatoses are rare tumors 1) that occasionally arise from thoracotomy scars. 2,3) They are locally aggressive tumors that occasionally exhibit local recurrence after resection. 4) Desmoid tumors arising from thoracotomy scars in patients with lung cancer should be discriminated from chest wall recurrence or dissemination of lung cancer. To address this issue, we present our case and review cases of desmoid-type fibromatosis following a previous thoracotomy that were reported in English or Japanese.
biopsy of the tumor revealed only fibrous tissue without tumor cells. Eighteen months after the first biopsy, CT revealed growth of the tumor, which reached 4.4 cm in diameter, and PET revealed mild FDG accumulation with an SUV max of 2.7 (Fig. 1B) . The CEA level was 2.0 ng/ml. CT-guided biopsy revealed the same histology as the previous biopsy. Four months after the second biopsy, the size of the tumor on CT reached a maximal diameter of 7.4 cm. The tumor was removed without rib resection because the tumor was well circumscribed without invasiveness. No hemorrhage or necrosis occurred in the tumor (Fig. 2) . Microscopically, the tumor was composed of spindle cells in abundant collagenous tissue ( Fig. 3) . Immunohistochemically, the spindle cells were positive for vimentin and b-catenin, and negative for cytokeratin and CD34. These results were consistent with desmoid-type fibromatosis. Our patient underwent mastectomy for ipsilateral breast cancer 3 years after chest wall surgery, and she is currently alive without recurrence 4 years after surgery for desmoid-type fibromatosis.
Discussion
Since Giustra, et al. first reported a case of desmoidtype fibromatosis arising from a previous thoracotomy site in 1976, 2) there have been several cases reported ( Table 1) . 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Desmoid-type fibromatosis following thoracotomy for malignancy should be discriminated from chest wall recurrence or dissemination of the previous disease. The tumors can be divided into chest wall and intrathoracic desmoid-type fibromatoses ( Table 1) . Intrathoracic desmoid-type fibromatosis following thoracotomy should also be discriminated from solitary fibrous tumors. Some intrathoracic desmoid-type fibromatoses following thoracotomy were found in an area separate from the previous thoracotomy site ( Table 1) .
Of seven cases who underwent preoperative needle biopsies, only one case had a definite diagnosis of desmoidtype fibromatosis. It may be difficult to obtain a definite diagnosis of desmoid-type fibromatosis following thoracotomy by needle biopsy. FDG-PET plays an important role in the identification of lung cancer recurrence. 17) A desmoid-type fibromatosis arising from a thoracotomy scar mimics the chest wall or pleural recurrence of lung cancer. Although lung cancer with recurrence exhibits high FDG accumulation on PET, the tumor in cases of desmoid-type fibromatosis following thoracotomy exhibited mild FDG accumulation in PET analysis (SUV max : 2.7-2.8, Table 1 ). There were 2 reports of FDG-PET for desmoid-type fibromatosis. Souza, et al. reported a chest wall desmoid tumor (9 cm in diameter) that also had a mild SUV max of 1.7. 18) Conversely, Kasper, et al. performed FDG-PET analysis of 16 patients with desmoid tumors, for whom the median SUV max was 4.1 (range: 1.0-8.1). 19) Although FDG-PET was useful for discriminating benign tumors from lung cancer recurrence, further emanation of PET for desmoid-type fibromatosis is needed.
Wide surgical resection is recommended for desmoidtype fibromatoses. 20) Rib resection was performed for all previous reported cases of desmoid-type fibromatosis following thoracotomy ( Table 1) . Since the tumor here was well circumscribed without invasiveness, we performed rib-sparing resection, and the patient has survived without recurrence for 4 years. Kim, et al. reported a case of chest wall desmoid tumor that was resected by thoracoscopic surgery, and this patient has survived without recurrence for 6 years. 21) The safe surgical margin for desmoid-type fibromatosis is uncertain.
A "wait and watch" policy has become popular in the management of desmoid-type fibromatosis. 20) In biopsydiagnosed desmoid-type fibromatosis arising from a thoracotomy scar, "wait and watch" policy may be an effective management options.
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